NOBEL BIOCARE DANMARK A/S: Financial statements 2024
CVR: 28293364
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
NOBEL BIOCARE DANMARK A/S (CVR 28293364) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 3,772,945 and a net result of DKK -4,496,854 compared with DKK -2,013,483 the year before. That is an increase of 20.8% compared with the year before. Equity in the 2024 report amounted to DKK -6,141,091. The company had 3 employees in the financial year.
- Gross Profit
- DKK 3,772,945
- Profit/Loss
- DKK -4,496,854
- Equity
- DKK -6,141,091
- Total Assets
- DKK 160,036,993
- Employees
- 3
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 3.8M | -4.5M | -6.1M | 3 |
| 2023 | - | 3.1M | -2M | -1.6M | 4 |
| 2022 | - | 3.3M | -489K | 369K | 3 |
| 2021 | - | 4.3M | 268K | 858K | 3 |
| 2020 | - | 4.8M | -794K | -1.4M | 5 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
NOBEL BIOCARE DANMARK A/S has published its annual report for 2023. Gross profit came to DKK 3,122,730, and the net result was DKK -2,013,483.
About NOBEL BIOCARE DANMARK A/S
NOBEL BIOCARE DANMARK A/S is a Danish company of the type Aktieselskab based in Silkeborg, founded in 2004. The company is registered under the industry Fremstilling af medicinske og dentale instrumenter samt udstyr hertil. The management consists of Jan Jerne. The board consists of Magnus Karl Andreas Pettersson (chair), Harrieth Eva Elisabeth Sundaeus and Jan Jerne. The company is owned by Nobel Biocare AB. The company has 4 employees (2026). In 2025, the company reported a gross profit of DKK 4,044,322 and a net result of DKK -4,810,707 compared with DKK -4,496,854 the year before. Equity in the 2025 report amounted to DKK -10,951,798.